Perfluorohexanesulfonic acid


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000067877 Autism Spectrum Disorder PMID:32353786
MESH:D001289 Attention Deficit Disorder with Hyperactivity PMID:20551004
MESH:D001724 Birth Weight PMID:29518214; PMID:36920051
MESH:D001835 Body Weight PMID:33208860; PMID:34464680
MESH:D001943 Breast Neoplasms PMID:28610584; PMID:32580117
MESH:D003072 Cognition Disorders PMID:23287389
MESH:D003924 Diabetes Mellitus, Type 2 PMID:33993001
MESH:D005234 Fatty Liver PMID:21705711
MESH:D005313 Fetal Death PMID:37315490
MESH:D006529 Hepatomegaly PMID:21705711; PMID:28049043; PMID:28558994; PMID:34464680
MESH:D006973 Hypertension PMID:32958007
MESH:D007889 Leiomyoma PMID:37224071
MESH:D009373 Neoplasms, Germ Cell and Embryonal PMID:32581411
MESH:D009385 Neoplastic Processes PMID:37224071
MESH:D010024 Osteoporosis PMID:26058082
MESH:D011041 Poisoning PMID:22302310
MESH:D011297 Prenatal Exposure Delayed Effects PMID:32353786; PMID:34500360; PMID:37283528
MESH:D012893 Sleep Wake Disorders PMID:39512894
MESH:D015430 Weight Gain PMID:33387635; PMID:37283528
MESH:D050171 Dyslipidemias PMID:21705711
MESH:D065626 Non-alcoholic Fatty Liver Disease PMID:28049043

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.